• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Reply to correspondence
Response to: Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era
Seren M. Gedallovich, Paul Y. Kwo
Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, California, USA
Correspondence :  Paul Y. Kwo ,
Email: pkwo@stanford.edu
Received: July 10, 2024   Accepted: July 11, 2024
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 413 View
  • 7 Download
Related articles

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication2024 July;30(3)

Development and prognosis of hepatocellular carcinoma in patients with diabetes2023 January;29(1)

Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review2022 October;28(4)

Long-term prognosis and management of hepatocellular carcinoma after curative treatment2020 October;26(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1735
TOTAL : 2092996
Close layer